Professor Georgina Long AO
BSc PhD MBBS FRACP FAHMS AAHMS FAA FASCO
Medical Director & Medical Oncologist
Professor Georgina Long AO, BSc (Hons1, UM) PhD MBBS (Hons) FRACP FAHMS AAHMS FAA FASCO, is Medical Director of Melanoma Institute Australia (MIA), and Chair of Melanoma Medical Oncology and Translational Research at MIA and Royal North Shore Hospital, The University of Sydney. She leads an extensive clinical trials team and laboratory at MIA, with a focus on immuno-oncology and targeted therapies in melanoma. She is principal investigator on phase I, II and III clinical trials in (neo)adjuvant and metastatic melanoma, including trials in patients with active brain metastases. She is the chief investigator on NHMRC funded research into the molecular biology of melanoma, with a particular interest in clinical and tissue biomarker correlates of systemic therapy sensitivity and resistance.
In recognition of her ground-breaking research and work, Professor Long was named 2024 Australian of the Year and was awarded prestigious Fellowships with the American Society for Clinical Oncology (2025), the Australian Academy of Science (2024) and the Australian Academy of Health and Medical Sciences (2017), the latter awarding her the Outstanding Female Research Medal (2021). Professor Long was appointed as an Officer of the Order of Australia (2020) and has received numerous awards, including Fulbright U.S. Mission Australia Award for Leadership Excellence (2024), Estela Medrano Melanoma Award (2024), ESMO Women for Oncology Award (2023), Sydney Local Health District/Sydney Research 2022 Research Excellence Award (2022) the prestigious Ramaciotti Medal for Biomedical Research (2021), Vice Chancellor’s Award for Excellence Award for Outstanding Research (2021), University of Sydney (2021), Research Australia GSK Research Excellence Award (2018) and the Sir Zelman Cowen Universities Fund Prize for Discovery in Medical Research (2016). She has a number of CINSW Premiers Awards, including: the Outstanding Cancer Researcher (2018), the Excellence in Translational Cancer Research Award (2017), the Wildfire Award for the most highly-cited, original, peer-reviewed article published (2011, 2014, 2016, 2017, 2018, 2019 & 2020), and in 2013 she was named the Outstanding Cancer Research Fellow. She is a Clarivate highly-cited Researcher from 2017, with an H index of 155.
Professor Long is the author of over 610 peer-reviewed publications in clinical and translational research in melanoma, including the New England Journal of Medicine, Lancet, Lancet Oncology, Science, Nature, Nature Medicine, Journal of Clinical Oncology and Cancer Discovery. Professor Long has presented her work at international conferences and meetings on more than 300 occasions. She was President for the prestigious international Society for Melanoma Research (President 2018-2020), is a member and Chair of the ASCO (2015-2017) and ESMO (2017-2020 & 2026 – 2029) Scientific Committee for Melanoma/Skin cancer, is medical oncology lead for the Australian Melanoma Management Guidelines Committee, and is member of both the ASCO Plenary Series and ASCO AGM Education committees (2021-2024), Scientific Co-Chair for ESMO Asia (2024) and EADO (2026), she is on the editorial boards of several high-impact journals, and is a member of the Melanoma Expert Panel for AJCC Cancer Staging System 8th edition.
Professor Long was awarded the University Medal in Organic Chemistry. She subsequently completed her PhD in Chemistry in the field of anti-cancer agents and their binding to DNA. She then moved to the USA to take up a Fulbright Postdoctoral Fellowship at Scripps Research Institute, exploring nanotechnology in cancer treatment, before returning to Australia to complete her MBBS (Hons). Professor Long became a Fellow of the Australasian College of Physicians in January 2008, specialising in medical oncology.
Prof Long Recent News
MIA researchers share latest melanoma breakthroughs at ESMO
Researchers and clinicians from Melanoma Institute Australia have played a leading role at the recent ESMO Congress in Paris.
National Press Club address on Wed 21 Sept
Olympian and melanoma survivor Cate Campbell, and Melanoma Institute Australia Co-Medical Directors Professor Georgina Long AO and Professor Richard Scolyer AO, will address the National Press Club of Australia.
MIA’s Prof Georgina Long AO named as world’s top melanoma expert
Prof Long has been named No 1 Melanoma Expert in worldwide rankings just released by expertscape, based on articles published 2012-2022.
MIA launches world-first tool to predict immunotherapy response
New clinical tool developed by Melanoma Institute Australia hailed a breakthrough in personalising treatment for all cancer patients.
Prof Long Recent Publications
Zemek RM, Anagnostou V, Pires da Silva I, Long GV, Lesterhuis WJ. Nature Reviews Cancer, doi:10.1038/s41568-024-00699-2. TOP 1%
Zemek RM, Anagnostou V, Pires da Silva I, Long GV, Lesterhuis WJ. Nature Reviews Cancer, (Jun 17 2024), doi:10.1038/s41568-024-00699-2. TOP 1%
Long GV, Hauschild A, Santinami M, Kirkwood JM, Atkinson V, Mandala M, Merelli B, Sileni VC, Nyakas M, Haydon A, Dutriaux C, Robert C, Mortier L, Schachter J, Schadendorf D, Lesimple T, Plummer R, Larkin J, Tan M, Adnaik SB, Burgess P, Jandoo T, Dummer R. New England Journal of Medicine, (Jun 19 2024), doi:doi:10.1056/NEJMoa2404139. TOP 1%
Blank CU, Lucas MW, Scolyer RA, van de Wiel BA, Menzies AM, Lopez-Yurda M, Hoeijmakers LL, Saw RPM, Lijnsvelt JM, Maher NG, Pulleman SM, Gonzalez M, Torres Acosta A, van Houdt WJ, Lo SN, Kuijpers AMJ, Spillane A, Klop WMC, Pennington TE, Zuur CL, Shannon KF, Seinstra BA, Rawson RV, Haanen J, Ch’ng S, Naipal KAT, Stretch J, van Thienen JV, Rtshiladze MA, Wilgenhof S, Kapoor R, Meerveld-Eggink A, Grijpink-Ongering LG, van Akkooi ACJ, Reijers ILM, Gyorki DE, Grünhagen DJ, Speetjens FM, Vliek SB, Placzke J, Spain L, Stassen RC, Amini-Adle M, Lebbé C, Faries MB, Robert C, Ascierto PA, van Rijn R, van den Berkmortel F, Piersma D, van der Westhuizen A, Vreugdenhil G, Aarts MJB, Stevense-den Boer MAM, Atkinson V, Khattak M, Andrews MC, van den Eertwegh AJM, Boers-Sonderen MJ, Hospers GAP, Carlino MS, de Groot JB, Kapiteijn E, Suijkerbuijk KPM, Rutkowski P, Sandhu S, van der Veldt AAM, Long GV. N Engl J Med, (Jun 2 2024), doi:10.1056/NEJMoa2402604. TOP 1%
Luke JJ, Long GV, Robert C, Carlino MS, Choueiri TK, Haas NB, O’Brien M, Paz-Ares L, Peters S, Powles T, Leiby MA, Lin J, Zhao Y, Krepler C, Perini RF, Catherine Pietanza M, Samkari A, Gruber T, Ibrahim N, Eggermont AMM. European Journal of Cancer, (May 31 2024): 114146, doi:https://doi.org/10.1016/j.ejca.2024.114146.
Chan WY, Lee J, Stewart A, Diefenbach RJ, Gonzalez M, Menzies AM, Blank CU, Scolyer RA, Long GV, Rizos H. Journal of Clinical Oncology, 42, no. 16_suppl, (May 29 2024): 9577-77, doi:10.1200/JCO.2024.42.16_suppl.9577.
Zijlker LP, Chen H, Spillane AJ, Gonzalez M, Pennington TE, Menzies AM, Lo SN, Ferguson P, Rawson R, Colebatch AJ, Stretch JR, Thompson JF, Ch’ng S, Nieweg O, Shannon KF, Long GV, Scolyer RA, Saw RPM, van Akkooi ACJ. Annals of Surgical Oncology, (May 18 2024), doi:10.1245/s10434-024-15274-0.
Robert C, Gastman B, Gogas H, Rutkowski P, Long GV, Chaney MF, Joshi H, Lin Y-L, Snyder W, Chesney JA. European Journal of Cancer, (May 15 2024): 114120, doi:https://doi.org/10.1016/j.ejca.2024.114120.
Robert C, Gastman B, Gogas H, Rutkowski P, Long GV, Chaney MF, Joshi H, Lin YL, Snyder W, Chesney JA. Eur J Cancer, 207(Aug 2024): 114120, doi:10.1016/j.ejca.2024.114120.
Menzies AM, Lo SN, Saw RPM, Gonzalez M, Ch’ng S, Nieweg OE, Shannon KF, Ferguson PM, Lee J, Emmett L, Kapoor R, Rawson RV, Stretch JR, Thompson JF, Spillane AJ, Rizos H, Scolyer RA, Long GV. Annals of Oncology, (May 14 2024), doi:10.1016/j.annonc.2024.05.002. TOP 10%
ZERO DEATHS FROM MELANOMA
Suzanne Sherwood says:
Steve Cole says:
Catherine Mardell says: